SCHEMBL6004732

SCHEMBL6004732

COc1ccc2c(C(=O)c3ccc(OCCC4CCCCN4)cc3)c(-c3cccc(F)c3F)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.43
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HIF1A Q16665 1/20 0.38
PHLPP2 Q6ZVD8 1/20 0.38
SSTR2 P30874 4/20 0.37
ESR1 P03372 4/20 0.36
ESR2 Q92731 3/20 0.36
KDM2B Q8NHM5 1/20 0.35
GCGR P47871 1/20 0.35
AURKB Q96GD4 1/20 0.35
SMYD3 Q9H7B4 1/20 0.35
HRH2 P25021 1/20 0.35
HRH1 P35367 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6005446 0.94 CHEK2 (0.44) CHEK2CYP1A2CYP2D6CYP2C19SMN1; SMN2
SCHEMBL6004724 0.93 CHEK2 (0.43) CHEK2CYP1A2CYP2D6CYP2C19SMN1; SMN2
SCHEMBL6005426 0.93 CHEK2 (0.43) CHEK2CYP1A2CYP2D6CYP2C19SMN1; SMN2
SCHEMBL6005698 0.93 CHEK2 (0.43) CHEK2CYP1A2CYP2D6CYP2C19SMN1; SMN2
SCHEMBL6005515 0.91 CHEK2 (0.42) CHEK2CYP1A2CYP2D6CYP2C19SMN1; SMN2
SCHEMBL6003264 0.91 CHEK2 (0.43) CHEK2CYP1A2CYP2D6CYP2C19SMN1; SMN2
SCHEMBL6004620 0.91 CHEK2 (0.44) CHEK2SSTR2ESR1ESR2
SCHEMBL6004684 0.90 CHEK2 (0.42) CHEK2CYP1A2CYP2D6CYP2C19SMN1; SMN2
SCHEMBL6003394 0.90 CHEK2 (0.43) CHEK2CYP1A2CYP2D6CYP2C19SMN1; SMN2
SCHEMBL6003300 0.89 CHEK2 (0.43) CHEK2CYP1A2CYP2D6CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1709021-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2006-10-11 EP disclosed
WO-2005073204-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2005-08-11 WO disclosed